• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Advil Challenges Sports Culture's "No Pain No Gain" Mentality This Summer

    6/9/26 7:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $HLN alert in real time by email

    The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like

    Key Takeaways:

    • Advil is launching Rewriting Pain, a new campaign challenging sports culture's "no pain no gain" mentality and redefining strength as confronting pain, not ignoring it.
    • New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success.
    • Legendary U.S. Men's National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and performance.
    • Advil's Rewriting Pain campaign will come to life through a New York City billboard reveal and soccer activation on June 10th, and social and digital content this summer.

    Today, Advil announced the launch of Rewriting Pain, a new initiative that challenges the narrative around pain in sports and encourages people to rethink what real strength looks like. As global attention turns to soccer this summer, Advil is stepping into the conversation with a clear message: it's time to rethink the long-held idea that playing through pain is a sign of strength. Centered on the idea that pain should be confronted, not ignored, the campaign challenges a culture that glorifies playing through pain and redefines strength as confronting pain so you can show up as your strongest self.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609276845/en/

    For generations, athletes have been taught exactly that – treating pain as a badge of honor rather than something to recognize and address responsibly. New research commissioned by Advil and Wakefield Research among current and former everyday athletes* reveals how deeply ingrained this mindset remains in sports culture:

    • 79% of athletes say phrases like "push through the pain" can encourage athletes to ignore body signals
    • 86% believe these phrases can put long-term health at risk
    • 78% admit they've played through pain to avoid letting others down
    • 87% agree that sports culture treats pain as a necessary part of success
    • 80% of athletes have continued participating in a sport despite being in pain because winning felt more important in the moment

    The findings point to a systemic issue in sports culture and underscore the need for a broader shift in how pain, recovery and strength are discussed. Through Rewriting Pain, Advil is challenging outdated attitudes around pain and encouraging athletes to rethink what real strength looks like.

    "As a leader in everyday pain management, Advil believes the conversation around pain in sports needs to evolve and we are ready to lead this shift," said Natalie Halpern, senior director of marketing for Advil at Haleon. "We believe true strength isn't pushing through pain, it's confronting it and treating it responsibly. When pain hits, Advil targets pain at the source of inflammation, which is why this conversation matters so deeply to us. For too long, athletes have been taught to power through pain as proof of toughness, when in reality, confronting your pain is what enables you to perform at your best. Through Rewriting Pain, we aim to spark a new dialogue around addressing pain, recovery and what it means to be strong both in sports and in everyday life."

    Advil is taking action by encouraging athletes and consumers alike to listen to their bodies and recognize that real strength comes from confronting pain, not pushing through it. When pain is confronted and addressed directly, Advil believes that is when you can show up as your strongest self. As part of the initiative, Advil will unveil a bold billboard reveal in New York City alongside a partnership with legendary U.S. Men's National Team forward and successful investor and entrepreneur, Jozy Altidore.

    Following the billboard reveal, Advil will host a preview event where attendees will hear from Jozy, step onto the pitch to test their skills, and have a candid sideline conversation about the pressure athletes face to play through pain. Advil's billboard and the Rewriting Pain activation will be open to the public to see the campaign in real life and test their soccer skills from 1:00 p.m. EST – 6:00 p.m. EST on Wednesday, June 10 at 410 Lafayette Street, New York, NY 10003. After June 10, Advil's Rewriting Pain campaign will be live across social and digital channels, supported by out-of-home placements in select markets.

    "Throughout my career, pushing through pain wasn't just encouraged; it was expected," said Altidore. "But I've learned that real strength comes from knowing when to address your pain, recover, and come back stronger. Advil has always been part of my recovery because it targets pain at the source of inflammation. That's why I'm proud to work with Advil to challenge the culture of pain management in sports head-on through this campaign. My hope is that this conversation helps show the next generation of athletes that they don't have to ignore pain to succeed."

    Rethink your definition of strength this summer and learn more about the Rewriting Pain campaign by following Advil on Instagram at @AdvilRelief.

    *Advil and Wakefield Research surveyed 1,000 U.S. adults (18+) who are current and former athletes in May 2026 with a web-based questionnaire. "Athletes" were defined as those who currently compete or have competed in a sport previously (e.g. collegiate, club, recreational, etc.). The respondent pool does not include professional athletes.

    About Haleon

    Haleon (LSE/NYSE:HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.

    About Advil

    Patients and doctors have relied on Advil to deliver powerful relief from several kinds of pain, including headache, muscle aches, minor arthritis and other joint pain, and backache for 40 years. Advil's line of products includes Advil Liqui-Gels, Advil Dual Action, Advil PM and Advil Tablets. To learn more about Advil, visit www.Advil.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260609276845/en/

    Media Contact

    Samya France

    Samya.France@edelman.com

    Get the next $HLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLN

    DatePrice TargetRatingAnalyst
    1/23/2026Equal Weight → Overweight
    Barclays
    9/16/2025Overweight → Equal Weight
    Barclays
    9/10/2025Neutral → Buy
    Goldman
    5/27/2025$13.40Neutral → Outperform
    BNP Paribas Exane
    5/9/2025$11.25Equal-Weight → Overweight
    Morgan Stanley
    3/5/2025Buy → Hold
    HSBC Securities
    1/10/2025Overweight → Equal-Weight
    Morgan Stanley
    1/8/2025Outperform → Mkt Perform
    Bernstein
    More analyst ratings

    $HLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Haleon plc upgraded by Barclays

    Barclays upgraded Haleon plc from Equal Weight to Overweight

    1/23/26 8:10:24 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc downgraded by Barclays

    Barclays downgraded Haleon plc from Overweight to Equal Weight

    9/16/25 8:03:47 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc upgraded by Goldman

    Goldman upgraded Haleon plc from Neutral to Buy

    9/10/25 7:56:26 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    SEC Filings

    View All

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    6/22/26 6:42:49 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    6/15/26 6:04:47 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Haleon plc

    6-K - Haleon plc (0001900304) (Filer)

    6/8/26 3:59:21 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    One in Three Western Consumers Now Buy Products Discovered on Social Platforms as AI Reshapes Commerce, According to NIQ

    New insights presented at The Consumer Goods Forum Global Summit highlight how AI is accelerating the convergence of global commerce models—reshaping growth strategies for brands and retailers NIQ (NYSE:NIQ), a leading consumer intelligence company, today revealed new analysis presented at The Consumer Goods Forum (CGF) Global Summit showing that nearly one in three consumers in Western markets now purchase products they first discover on social platforms, as artificial intelligence (AI) and emerging commerce models accelerate a shift toward discovery-led commerce. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626970024/en

    6/26/26 4:00:00 AM ET
    $NIQ
    $HLN
    Computer Software: Programming Data Processing
    Technology
    Package Goods/Cosmetics
    Consumer Discretionary

    Advil Challenges Sports Culture's "No Pain No Gain" Mentality This Summer

    The brand is launching Rewriting Pain, a new campaign and partnership with soccer legend Jozy Altidore to redefine what strength looks like Key Takeaways: Advil is launching Rewriting Pain, a new campaign challenging sports culture's "no pain no gain" mentality and redefining strength as confronting pain, not ignoring it. New research commissioned by Advil reveals 87% of current and former everyday athletes agree sports culture treats pain as a necessary part of success. Legendary U.S. Men's National Team forward and successful investor and entrepreneur, Jozy Altidore is partnering with Advil to encourage people to rethink outdated attitudes around pain, recovery and performance.

    6/9/26 7:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon Invests in India to Deliver Better Everyday Health to Rural Communities

    £175m for first Haleon manufacturing site in Madhya Pradesh, central India Fast-growing India key to Haleon reaching one billion more consumers by 2030 India's consumer health market to reach over £23bn by 20301 Accelerated rural distribution to access 3 million outlets Affordable Sensodyne packs and investment to double ‘last-mile' reach in rural areas Haleon, a consumer company that is solely focused on better everyday health, today announces plans to expand its business in India, one of its fastest-growing markets and key to Haleon delivering its strategy and ambitions to reach one billion more consumers by 2030. Haleon will invest approximately £175 million2 in building

    6/8/26 5:11:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Financials

    Live finance-specific insights

    View All

    Yellow Wood Partners Portfolio Company Suave Brands Company Completes ChapStick Acquisition

    BOSTON, June 3, 2024 /PRNewswire/ -- Yellow Wood Partners LLC ("Yellow Wood"), a Boston-based private equity firm known for investing in consumer brands and companies, is pleased to announce that its portfolio company, Suave Brands Company, has successfully completed the acquisition of the ChapStick brand from Haleon (NYSE:HLN). This transaction also results in Haleon becoming a shareholder in Suave Brands Company. Suave Brands Company Chief Executive Officer, Daniel Alter, said, "As we continue to build Suave Brands Company as the top independent North American beauty & personal care company by combining the agility of a start-up with the power of market leading brands, the addition of Cha

    6/3/24 7:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Yellow Wood Partners Portfolio Company Suave Brands Company Acquires ChapStick from Haleon

    BOSTON, Jan. 25, 2024 /PRNewswire/ -- Yellow Wood Partners ("Yellow Wood"), a Boston-based private equity firm focused on investing in consumer brands and companies, today announced that its portfolio company Suave Brands Company has signed a binding offer to acquire the ChapStick brand from Haleon (NYSE:HLN), a global leader in consumer health. The transaction is intended to close in the first half of 2024 upon completion of customary closing and regulatory approvals. ChapStick invented the lip care category in the 1880s with the launch of a now-iconic lip balm that made ChapStick a household name. For more than a century, ChapStick has added products to its portfolio with innovative new i

    1/25/24 2:05:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon plc Announces Expiration and Results of Exchange Offers for Certain Series of Notes Issued in Private Placements in Connection with the Separation from GSK

    Not for release, publication or distribution, directly or indirectly, in or into any jurisdiction into which such distribution would be unlawful. This notice is for informational purposes only and does not constitute an offer to purchase, or a solicitation of an offer to sell, any securities. The exchange offers referred to herein are being made solely pursuant to the Prospectus and related documents. The exchange offers referred to herein are not being made to holders of securities in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction. LONDON, Oct. 31, 2022 /PRNewswire/ -- Haleon plc ("Haleon

    10/31/22 10:20:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Haleon plc

    SC 13G - Haleon plc (0001900304) (Subject)

    11/13/24 1:20:28 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/3/24 6:59:16 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Haleon plc

    SC 13D/A - Haleon plc (0001900304) (Subject)

    10/1/24 7:38:46 PM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    $HLN
    Leadership Updates

    Live Leadership Updates

    View All

    Haleon Appoints Richard Manso as US Chief Marketing Officer to Advance Data-driven, Consumer-centric Marketing in Delivering Better Everyday Health

    Today Haleon (NYSE:HLN), the consumer company that is solely focused on better everyday health, announced the appointment of Richard Manso as US Chief Marketing Officer, effective April 27, 2026. In this role, Manso will partner closely with CEO, US & President, North America Nathalie Gerschtein and the US leadership team to accelerate Haleon's evolution into a more agile, consumer-centric organization. Manso will lead Haleon's integrated US marketing organization, advancing how the company connects with consumers in the moments where health decisions actually happen. He will work across categories and global teams to integrate data, technology and human insight, strengthening Haleon's ab

    4/27/26 10:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER

    LONDON, June 24, 2025 /PRNewswire/ -- Haleon (LSE: HLN) (NYSE:HLN) today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.  This appointment follows Franck Riot deciding to leave Haleon after six years in the business.  Carl joins Haleon from the Estée Lauder Companies Inc. where he has spent 13 years as Executive Vice President, Global Innovation and Research and Development. Carl previously spent over 20 years at P&G across Home, Health and Beauty Care.  Brian McNamara, Haleon's Chief Executive Officer commented: "I am delighted to welcome Carl to Haleon. Carl is a world-renowned leader in R&D, with significant experi

    6/24/25 8:00:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary

    Haleon Welcomes Joe Sta-Romana as Chief Customer Officer to Lead US Growth and Transformation

    WARREN, N.J., Dec. 2, 2024 /PRNewswire/ -- Haleon, a world-leading consumer health company, is pleased to announce the appointment of Joe Sta-Romana as Chief Customer Officer (CCO) for its US business, effective December 1, 2024.  In this role, Joe will lead the organization's customer strategy, driving growth and transformation in the US market. Joe brings extensive leadership experience to the role, having spent over 20 years in the FMCG sector and serving in the military. Most recently Joe led Unilever's Walmart business, overseeing the company's largest US customer. In his

    12/2/24 7:53:00 AM ET
    $HLN
    Package Goods/Cosmetics
    Consumer Discretionary